Press release - 18/04/2024 Collagen: Researchers at the NMI decipher how it works in medical treatment Collagen has been used in ophthalmology since the 1990s, particularly in the treatment of corneal defects. However, why and how this technique works was only known in theory. Researchers at the NMI Natural and Medical Sciences Institute in Reutlingen led by Lu Fan have found the necessary evidence and can now reliably explain how this technique works.https://www.gesundheitsindustrie-bw.de/en/article/press-release/collagen-researchers-nmi-decipher-how-it-works-medical-treatment
Press release - 13/03/2024 Diabetes: New technology opens up improved opportunities for research More than seven million people in Germany suffer from diabetes. At the same time, research into drugs to treat this widespread disease is still difficult. Scientists led by Prof. Dr. Peter Loskill from the NMI Natural and Medical Sciences Institute and the Faculty of Medicine of the Eberhard Karls University of Tübingen have now developed a technique that significantly improves the view at the molecular and cell biological level in the pancreas.https://www.gesundheitsindustrie-bw.de/en/article/press-release/diabetes-new-technology-opens-improved-opportunities-research
Press release - 02/02/2024 University of Stuttgart successful with cluster draft proposals The German Research Foundation (DFG) has announced the first pivotal decisions for the "Clusters of Excellence" funding line as part of the Excellence Strategy of the German federal and state governments. The University of Stuttgart has been given the green light for two new cluster initiatives. https://www.gesundheitsindustrie-bw.de/en/article/press-release/universitaet-stuttgart-mit-clusterskizzen-erfolgreich
Press release - 17/01/2024 Immatics Announces Pricing of $175 Million Public Offering Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, announced today the pricing of an underwritten public offering of 15,925,000 ordinary shares at a public offering price of $11.00 per share. https://www.gesundheitsindustrie-bw.de/en/article/press-release/immatics-announces-pricing-175-dollar-million-public-offering
Health Data Futures project - 11/01/2024 Creating a network of trust In the three-nation project "Health Data Futures", stakeholders and experts from Germany, France and Switzerland have launched a series of patient-centred innovations. Using various future scenarios, the project partners may be able to come up with even more scenarios.https://www.gesundheitsindustrie-bw.de/en/article/news/creating-network-trust
Press release - 10/01/2024 MedTech Company KARL STORZ Acquires British AI Specialist Innersight Labs The family-owned MedTech company KARL STORZ announces the acquisition of the innovative software manufacturer Innersight Labs Ltd. (ISL) headquartered in London. In addition to state-of-the-art endoscopes, high-end medical devices, and integrated solutions for the operating room, KARL STORZ is also continuing to expand in innovative software solutions. https://www.gesundheitsindustrie-bw.de/en/article/press-release/medtech-company-karl-storz-acquires-british-ai-specialist-innersight-labs
ProGrün project - 30/12/2023 Using proteins extracted from grassland cuttings to produce animal feed and exploit by-product streams Animal feed often contains protein from soy and importing it causes major environmental harm. In the ProGrün project, researchers at the University of Hohenheim, including a work group led by Prof. Dr. Andrea Kruse, are developing a scalable technological process to extract proteins from grassland cuttings and use them to make sustainable animal feed produced in the region where it will be used.https://www.biooekonomie-bw.de/en/articles/news/using-proteins-extracted-grassland-cuttings-produce-animal-feed-and-exploit-product-streams
Press release - 11/12/2023 Heidelberg center for personalized medicine achieves the highest quality standards The German Cancer Society has certified the Center for Personalized Medicine (ZPM) at Heidelberg University Hospital. At the ZPM Heidelberg, patients with advanced and rare cancers and, in future, people with severe chronic inflammatory diseases will receive a molecular genetic analysis. The detailed information can open up new treatment options for those affected.https://www.gesundheitsindustrie-bw.de/en/article/press-release/zentrum-fuer-personalisierte-medizin-heidelberg-erfuellt-hoechste-qualitaetsstandards
urban BioEconomyLab - 07/12/2023 The city as a living laboratory for a bioeconomic, sustainable economic area Baden-Württemberg is leading the way in the transition to a climate-neutral and sustainable economy. One of the projects undertaken is the Fraunhofer IGB’s "urban BioEconomyLab" project which aims to develop a transformation model and living laboratory to find bioeconomic solutions for the sustainable design of cities and municipal industry. What is new is that the IGB takes a systemic approach, focusing on biobased and circular value…https://www.biooekonomie-bw.de/en/articles/news/city-living-laboratory-bioeconomic-sustainable-economic-area
The AlbLavendel project - 20/11/2023 Swabian lavender cultivation: aesthetic and sustainable Blue-violet, fragrant fields like those in Provence may soon become a common sight in the Swabian Alb. As part of the AlbLavendel project, the University of Hohenheim along with the company naturamus GmbH and the German Institutes of Textile and Fibre Research Denkendorf has started to investigate the cultivation of lavender, the production of essential oils and the use of distillation residues for producing textile fibres in the local region.https://www.biooekonomie-bw.de/en/articles/news/swabian-lavender-cultivation-aesthetic-and-sustainable
Press release - 02/11/2023 Sustainability Innovation Campus The Sustainability Innovation Campus (ICN) initiated by the University of Freiburg and the Karlsruhe Institute of Technology (KIT), which will begin its work in January 2024, has announced a two-year funding programme for start-up projects. Scientists from the University of Freiburg, KIT and cooperating universities and research institutions are invited to submit their project outlines by 30 November 2023.https://www.biooekonomie-bw.de/en/articles/pm/sustainability-innovation-campus
Dossier - 11/10/2023 The quantum revolution in the healthcare industry From ultra-fast quantum computers to highly sensitive sensors - quantum technologies could take medicine a giant step forward. Possible areas of application range from drug development and early cancer detection to reading brain waves to control prostheses or exoskeletons. The German state of Baden-Württemberg plays a key role in the development of sensors in particular.https://www.gesundheitsindustrie-bw.de/en/article/dossier/The-quantum-revolution-in-the-healthcare-industry
More staff and digitalisation needed - 11/10/2023 International healthcare professionals The demand for skilled workers in Germany is high - especially in the healthcare sector. But the procedure for hiring and recognising qualifications is complex. In Baden-Württemberg, the Welcome Center Sozialwirtschaft Baden-Württemberg is one of the contact points for companies and professionals seeking advice on the process.https://www.forum-gesundheitsstandort-bw.de/en/information-and-press/news-and-press/international-healthcare-professionals
Press release - 04/10/2023 Therapeutic option for tumor patients with the rare DNAJB1-PRKACA gene fusion A phase I clinical trial is now starting at Tuebingen University Hospital in the Clinical Collaboration Unit (CCU) Translational Immunology, in collaboration with the Department of Internal Medicine I, which is investigating the therapeutic cancer peptide vaccine Fusion-VAC-XS15 in combination with immune checkpoint blockade by atezolizumab (Tecentriq®). https://www.gesundheitsindustrie-bw.de/en/article/press-release/therapeutic-option-tumor-patients-rare-dnajb1-prkaca-gene-fusion
Event - 15/11/2023 Networking Evening | Baden-Württemberg meets United Kingdom 2023 Medica trade fair, Baden-Württemberg joint booth K16, Hall 15, Messe https://www.gesundheitsindustrie-bw.de/en/event/networking-evening-baden-wuerttemberg-meets-united-kingdom-2023
Event - 15/11/2023 Networking Evening | Baden-Württemberg meets United Kingdom 2023 Medica trade fair, Baden-Württemberg joint booth K16, Hall 15, Messe https://www.bio-pro.de/en/events/past-events/networking-evening-baden-wuerttemberg-meets-united-kingdom-2023
Press release - 20/07/2023 Animal testing under REACH: bringing numbers into the debate So far, 4.2 million animal tests under the REACH chemical regulation: A study from Konstanz and Baltimore quantifies the number of animals that died for the hazard assessment of chemicals in the chemical industry.https://www.gesundheitsindustrie-bw.de/en/article/press-release/tierversuche-durch-reach-zahlen-die-debatte-bringen
Press release - 18/07/2023 National Research Center for cutting-edge AI research in Tübingen celebrates inception On Tuesday, July 18, 2023, the Tübingen AI Center held a symposium to celebrate its permanent establishment as a national AI center. Since July 1, 2022, it has received 20 million euros a year in funding from the federal government and the state. https://www.gesundheitsindustrie-bw.de/en/article/press-release/nationales-forschungszentrum-fuer-ki-spitzenforschung-tuebingen-feiert-seine-gruendung
Expert interview - 28/06/2023 Money isn't all that is needed – knowledge and networking can also help start-ups move forward Dr. Rolf Neuhaus is one of the driving forces behind PALATINA Business Angels Rhein-Neckar e.V., a business angels association in the Rhine-Neckar metropolitan region. In an interview with BIOPRO, Neuhaus describes the association’s activities and explains where there is still catching up to be done in terms of start-up support in Baden-Württemberg.https://www.gesundheitsindustrie-bw.de/en/article/news/money-isnt-all-needed-knowledge-and-networking-can-also-help-start-ups-move-forward
Detecting drug resistance of tumour cells - 25/05/2023 AI-assisted diagnostics declares war on lung cancer Lung cancer is one of the most common cancers and has a particularly high mortality rate. A significant challenge in treating this disease lies in the resistance of lung tumours to conventional drug therapies, rendering chemotherapy ineffective. There is hope on the horizon as a team of experts from Baden-Württemberg has joined forces to develop an innovative AI-supported test procedure that paves the way for individualised therapy approaches.https://www.gesundheitsindustrie-bw.de/en/article/news/ai-assisted-diagnostics-declares-war-lung-cancer
Press release - 21/04/2023 New research building for engineering life-inspired molecular systems Heidelberg University is to acquire a research building to develop innovative engineering science strategies and technologies on the basis of life-inspired molecular systems. The German Science and Humanities Council has now expressed its backing for the idea with an outstanding rating. This recommendation is the crucial precondition for a new building on the university campus Im Neuenheimer Feld. https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-research-building-engineering-life-inspired-molecular-systems
Overview The Phytopharmaceuticals and Valuable Plant Ingredients initiative The Phytopharmaceuticals and Valuable Plant Ingredients initiative aims to further develop phytopharmaceuticals and valuable plant ingredients in Baden-Württemberg.https://www.bio-pro.de/en/projects/healthcare-industry/phytopharmaceuticals-and-valuable-plant-ingredients-initiative
Event - 10/05/2023 Israel-Baden-Württemberg Innovation Summit Reutlingen, Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/israel-baden-wuerttemberg-innovation-summit
Press release - 31/03/2023 Simulation of Miscanthus- and Sorghum-based resilient value chains in the Danube Region Can the value chains in the Danube macro-region be more sustainable and resilient against disruptions such as pandemics? How modelling could help to simulate the economic viability of developing Miscanthus and Sorghum based value chains in that region?https://www.bio-pro.de/en/information/press-release/simulation-miscanthus-and-sorghum-based-resilient-value-chains-danube-region
Residual materials with potential - 16/03/2023 PeePower™ – energy from urine The objective of the PeePower™ BUGA 2023 collaborative research project is to produce green hydrogen and platform chemicals from wastewater. This fits in nicely with BUGA 2023’s (German National Garden Show) four major themes, namely, climate, energy, environment and food security.https://www.biooekonomie-bw.de/en/articles/pm/peepower-energy-urine
Networking event with 1:1 meetings - 11/05/2023 - 12/05/2023 Meet & Match Future Medicine Online, Registration deadline: 09/05/2023, Meet & Match https://www.gesundheitsindustrie-bw.de/en/event/meet-match-future-medicine
Networking event with 1:1 meetings - 11/05/2023 - 12/05/2023 Meet & Match Future Medicine Online, Registration deadline: 09/05/2023, Meet & Match https://www.bio-pro.de/en/events/meet-match-future-medicine
Expert interview - 08/03/2023 How do new active substances from university research reach patients? Access to capital remains one of the biggest challenges in the life sciences sector. Over the last two years, the Baden-Württemberg Center for Academic Drug Discovery (BWCAD2) has successfully implemented a model of cooperation between academic drug research and industry for the development and validation of therapeutic concepts. Dr. Barbara Jonischkeit spoke with the initiator and leading figure behind the BWCAD2 project, Prof. Dr. Stefan Lauferhttps://www.gesundheitsindustrie-bw.de/en/article/news/how-do-new-active-substances-university-research-reach-patients
Press release - 16/02/2023 Minister of Science Visits University of Freiburg On February 16, 2023, Baden-Württemberg’s Minister of Science, Research and the Arts, Petra Olschowski, visited the University of Freiburg. The focus of her visit was on sustainability and the transfer of knowledge. The minister learned all about how the day-to-day running of the university is becoming sustainable, and the wide-ranging climate protection and environmental safety measures. She also visited the livMatS pavilion.https://www.biooekonomie-bw.de/en/articles/pm/minister-science-visits-university-freiburg
Press release - 07/02/2023 Hertie Foundation establishes new institute combining artificial intelligence and neuroscience This month marks the launch of an outstanding project integrating artificial intelligence (AI) and neuromedicine – the Hertie Institute for Artificial Intelligence in Brain Health (Hertie AI). Founded on February 1 at the Medical Faculty of the University of Tübingen, it will be the first institute in Germany to research the prevention and early diagnosis of diseases of the nervous system using artificial intelligence methods.https://www.gesundheitsindustrie-bw.de/en/article/press-release/hertie-stiftung-gruendet-neues-institut-das-kuenstliche-intelligenz-und-neurowissenschaften-verbindet
Event - 07/03/2023 UK – Germany Bilateral: Collaborative R&D Funding for Innovation Online, Registration deadline: 06/03/2023, Informationsveranstaltung https://www.gesundheitsindustrie-bw.de/en/event/uk-germany-bilateral-collaborative-rd-funding-innovation
Event - 07/03/2023 UK – Germany Bilateral: Collaborative R&D Funding for Innovation Online, Registration deadline: 06/03/2023, Informationsveranstaltung https://www.bio-pro.de/en/events/uk-germany-bilateral-collaborative-rd-funding-innovation
Press release - 06/02/2023 Fewer side effects thanks to personalised medicine Patients have 30 percent fewer serious side effects when medication doses are tailored to their genetic profile. This is what an international research consortium has found out, including the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology at the Bosch Health Campus. With an individual DNA medication pass, as used in the study, treatments can be made more effective and safer in the future.https://www.gesundheitsindustrie-bw.de/en/article/press-release/weniger-nebenwirkungen-dank-personalisierter-medizin
Press release - 03/02/2023 Health + Life Science Alliance Heidelberg Mannheim officially founded Non-profit limited liability company creates institutional framework for interdisciplinary research collaboration, innovative technology development and outstanding healthcare in the Rhine-Neckar region.https://www.gesundheitsindustrie-bw.de/en/article/press-release/offizielle-gruendung-der-health-life-science-alliance-heidelberg-mannheim
Synergistic effects with microalgae and purple bacteria - 03/02/2023 Working towards a hydrogen economy with a wastewater biorefinery: the SmartBioH2-BW project A biorefinery that uses industrial wastewater and residual material streams is being built in Rheinfelden (Baden). It will have two interlinking bioreactors and will synthesize biohydrogen as well as organic basic materials such as carotenoids and proteins. SmartBioH2-BW is a pilot project run by the Urban and Industrial Biorefineries initiative and funded by the Baden-Württemberg Ministry of the Environment, Climate Protection and Energy Sector.https://www.biooekonomie-bw.de/en/articles/news/working-towards-hydrogen-economy-wastewater-biorefinery-smartbioh2-bw-project
Photon-counting technology - 01/02/2023 PC3 consortium: innovative computed tomography for Baden-Württemberg The University Hospitals of Freiburg, Tübingen and Mannheim have been cooperating with each other since 2021 to test new types of computed tomography devices. With the help of photon-counting technology, the aim is not only to improve patient care, but also to encourage local companies to develop downstream data processing technologies.https://www.gesundheitsindustrie-bw.de/en/article/news/pc3-consortium-innovative-computed-tomography-baden-wuerttemberg
Event - 02/03/2023 Lunch & Learn Greener NHS: UK´s roadmap to more sustainability in the health system Online, Registration deadline: 01/03/2023, Information Event https://www.gesundheitsindustrie-bw.de/en/event/lunch-learn-greener-nhs-uk-s-roadmap-more-sustainability-health-system
Event - 02/03/2023 Lunch & Learn Greener NHS: UK´s roadmap to more sustainability in the health system Online, Registration deadline: 01/03/2023, Information Event https://www.bio-pro.de/en/events/lunch-learn-greener-nhs-uk-s-roadmap-more-sustainability-health-system
Press release - 16/01/2023 GoDanuBio’s contribution to the bioeconomisation of the Danube Region GoDanuBio supported the set-up of policy frameworks and participative governance schemes in the participating regions. The main topics were circular bioeconomy, sustainable rural development and rural-urban interactions.https://www.bio-pro.de/en/information/press-release/aufbruch-zu-mehr-biooekonomie-im-donauraum
Valorization of biological materials - 12/01/2023 ValBio-Urban brings bioeconomy research to users Reducing carbon dioxide emissions and the capture and utilization of CO2 are important steps towards achieving a climate-neutral and sustainable economy. Accordingly, as part of the ValBio-Urban research project, an interdisciplinary team from the University of Stuttgart is developing bioeconomic approaches to solutions that will be implemented with companies from Baden-Württemberg.https://www.biooekonomie-bw.de/en/articles/news/valbio-urban-brings-bioeconomy-research-users
Start-up 'Innovation Matters' - 19/12/2022 Saffron cultivation in Germany - sustainable with support from robots Saffron is one of the most expensive spices in the world, because picking it involves a complex manual process. This treasure therefore comes to us mostly from countries such as Iran with poor working conditions and low wages. A start-up company called Innovation Matters from Baden-Württemberg is now developing a robot-assisted, automated process that will make saffron cultivation attractive in Germany as well as ecological and fair.https://www.biooekonomie-bw.de/en/articles/news/saffron-cultivation-germany-sustainable-support-robots
With insects to the circular economy - 30/11/2022 InBiRa: Insect biorefinery turns food leftovers into new products Insect larvae can convert food leftovers and waste into secondary raw materials for technical products and cosmetics. Researchers are looking to establish an insect biorefinery for this purpose at the Fraunhofer IGB in Stuttgart. The InBiRa project is financed with a total of 3.8 million euros in EU and Baden-Württemberg state funding.https://www.biooekonomie-bw.de/en/articles/news/inbira-insect-biorefinery-turns-food-leftovers-new-products
Press release - 29/11/2022 Prototype funding for two Konstanz projects Chemical building blocks from plastic waste; Reducing the risk of falls using virtual orientation aids: Konstanz chemists Manuel Häußler and Lukas Odenwald as well as sport scientist Lorenz Assländer receive Baden-Württemberg prototype funding for their transfer projects "Waste2DCA" and "Augmented Balance".https://www.gesundheitsindustrie-bw.de/en/article/press-release/doppelter-erfolg-der-prototypenfoerderung
Press release - 29/11/2022 Prototype funding for two Konstanz projects Chemical building blocks from plastic waste; Reducing the risk of falls using virtual orientation aids: Konstanz chemists Manuel Häußler and Lukas Odenwald as well as sport scientist Lorenz Assländer receive Baden-Württemberg prototype funding for their transfer projects "Waste2DCA" and "Augmented Balance".https://www.biooekonomie-bw.de/en/articles/pm/doppelter-erfolg-der-prototypenfoerderung
Press release - 29/11/2022 Five European pilot regions are joining forces for the bioeconomy BIOPRO Baden-Württemberg participates in the Horizon Europe ROBIN project to improve the participation of regional bioeconomy strategies and related policies across Europe.https://www.bio-pro.de/en/information/press-release/five-european-pilot-regions-are-joining-forces-bioeconomy
Press release - 29/11/2022 Five European pilot regions are joining forces for the bioeconomy BIOPRO Baden-Württemberg participates in the Horizon Europe ROBIN project to improve the participation of regional bioeconomy strategies and related policies across Europe.https://www.biooekonomie-bw.de/en/articles/pm/fuenf-europaeische-pilotregionen-schliessen-sich-fuer-die-biooekonomie-zusammen
Event - 16/11/2022 Networking Evening | Baden-Württemberg meets United Kingdom MEDICA Trade Fair, Joint Baden-Württemberg Booth, Hall 15/ Booth K16, Networking event https://www.gesundheitsindustrie-bw.de/en/event/networking-evening-baden-wuerttemberg-meets-united-kingdom
Event - 16/11/2022 Networking Evening | Baden-Württemberg meets United Kingdom MEDICA Trade Fair, Joint Baden-Württemberg Booth, Hall 15/ Booth K16, Networking event https://www.bio-pro.de/en/events/past-events/networking-evening-baden-wuerttemberg-meets-united-kingdom
Press release - 21/10/2022 Drei Jahre ICM: ressourcenschonend Produzieren – emissionsfrei Fahren Mobil bleiben und produzieren, ohne die natürliche Regenerationsfähigkeit der Erde zu überfordern, das ist der Anspruch des InnovationsCampus Mobilität der Zukunft (ICM) am Karlsruher Institut für Technologie und der Universität Stuttgart. Fast 300 Forschende in gut 60 Forschungsprojekten und 40 -instituten arbeiten hier an Elektromotoren ohne Seltene Erden, neuartigen Fertigungstechnologien und selbstlernenden Software-Systemen für Fahrzeuge.https://www.bio-pro.de/en/activities/biological-transformation/aktuelles/drei-jahre-icm-ressourcenschonend-produzieren-emissionsfrei-fahren